Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/30/13
End: 09/30/16
Due: 09/30/17
Phase: N/A
Priority: Normal
Start: 06/01/18
End: 12/30/20
Due: 12/30/21
Phase: N/A
Priority: Normal
Start: 02/28/07
End: 11/30/12
Due: 11/30/13
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| The Effect of Corticotrophin (ACTH) in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients | NCT01948388 | Gaylis, Norman B., M.D. | user2@example.com | None | 2013-09-30 | 2016-09-30 | 2017-09-30 | - | - | 2025-07-14 |
| Measurement of the Structural Efficacy in Active RA Patients Treated With Sarilumab in Combination With MTX and Naive to Biologics | NCT03535402 | Gaylis, Norman B., M.D. | user2@example.com | None | 2018-06-01 | 2020-12-30 | 2021-12-30 | - | - | 2025-07-14 |
| Impact of Rituximab on MRI Evidence of Disease Activity in Patients With Moderate to Severe Rheumatoid Arthritis | NCT00425932 | Gaylis, Norman B., M.D. | user2@example.com | None | 2007-02-28 | 2012-11-30 | 2013-11-30 | - | - | 2025-07-14 |